These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
439 related articles for article (PubMed ID: 32303607)
21. Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry. Brenner EJ; Ungaro RC; Gearry RB; Kaplan GG; Kissous-Hunt M; Lewis JD; Ng SC; Rahier JF; Reinisch W; Ruemmele FM; Steinwurz F; Underwood FE; Zhang X; Colombel JF; Kappelman MD Gastroenterology; 2020 Aug; 159(2):481-491.e3. PubMed ID: 32425234 [TBL] [Abstract][Full Text] [Related]
22. The management of inflammatory bowel diseases in the era of COVID-19 pandemic: When "non-urgent" does not mean "deferrable". Pugliese D; Papi C; Privitera G; Aratari A; Festa S; Armuzzi A Dig Liver Dis; 2020 Nov; 52(11):1238-1240. PubMed ID: 32601025 [No Abstract] [Full Text] [Related]
23. How to manage rheumatic patients during the coronavirus pandemic. Parisi S; Ditto MC; Finucci A; Fusaro E Panminerva Med; 2020 Sep; 62(3):176-177. PubMed ID: 32343511 [No Abstract] [Full Text] [Related]
24. Screening for active COVID-19 infection and immunization status prior to biologic therapy in IBD patients at the time of the pandemic outbreak. Zingone F; Buda A; Savarino EV Dig Liver Dis; 2020 Jun; 52(6):604-605. PubMed ID: 32360133 [TBL] [Abstract][Full Text] [Related]
25. Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers. Stallmach A; Sturm A; Blumenstein I; Helwig U; Koletzko S; Lynen P; Schmidt C; Dignass A; Kucharzik T; Z Gastroenterol; 2020 Oct; 58(10):982-1002. PubMed ID: 33036052 [TBL] [Abstract][Full Text] [Related]
26. COVID-19 Pandemic: Which IBD Patients Need to Be Scoped-Who Gets Scoped Now, Who Can Wait, and how to Resume to Normal. Ng SC; Mak JWY; Hitz L; Chowers Y; Bernstein CN; Silverberg MS J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S791-S797. PubMed ID: 33085973 [TBL] [Abstract][Full Text] [Related]
27. Inflammatory Bowel Disease Management During the COVID-19 Outbreak: The Ten Do's and Don'ts from the ECCO-COVID Taskforce. Magro F; Rahier JF; Abreu C; MacMahon E; Hart A; van der Woude CJ; Gordon H; Adamina M; Viget N; Vavricka S; Kucharzik T; Leone S; Siegmund B; Danese S; Peyrin-Biroulet L J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S798-S806. PubMed ID: 32722754 [TBL] [Abstract][Full Text] [Related]
28. How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion. Sarzi-Puttini P; Marotto D; Antivalle M; Salaffi F; Atzeni F; Maconi G; Monteleone G; Rizzardini G; Antinori S; Galli M; Ardizzone S Autoimmun Rev; 2020 Jul; 19(7):102574. PubMed ID: 32376399 [TBL] [Abstract][Full Text] [Related]
29. COVID-19 in a Kidney Transplant Patient. Wang J; Li X; Cao G; Wu X; Wang Z; Yan T Eur Urol; 2020 Jun; 77(6):769-770. PubMed ID: 32273181 [No Abstract] [Full Text] [Related]
31. Life in lockdown: experiences of patients with IBD during COVID-19. Harris RJ; Downey L; Smith TR; Cummings JRF; Felwick R; Gwiggner M BMJ Open Gastroenterol; 2020 Nov; 7(1):. PubMed ID: 33214234 [TBL] [Abstract][Full Text] [Related]
32. Challenges in paediatric inflammatory bowel diseases in the COVID-19 time. Dipasquale V; Cucchiara S; Martinelli M; Miele E; Aloi M; Romano C Dig Liver Dis; 2020 May; 52(5):593-594. PubMed ID: 32276846 [No Abstract] [Full Text] [Related]
33. Management of inflammatory bowel disease patients in the COVID-19 pandemic era: a Brazilian tertiary referral center guidance. Queiroz NSF; Barros LL; Azevedo MFC; Oba J; Sobrado CW; Carlos AS; Milani LR; Sipahi AM; Damião AOMC Clinics (Sao Paulo); 2020; 75():e1909. PubMed ID: 32321117 [TBL] [Abstract][Full Text] [Related]
34. Audio Interview: Caring for Patients with Covid-19. Rubin EJ; Baden LR; Morrissey S N Engl J Med; 2020 Apr; 382(16):e50. PubMed ID: 32294372 [No Abstract] [Full Text] [Related]
35. COVID-19 challenge for modern medicine. Dzieciatkowski T; Szarpak L; Filipiak KJ; Jaguszewski M; Ladny JR; Smereka J Cardiol J; 2020; 27(2):175-183. PubMed ID: 32286679 [TBL] [Abstract][Full Text] [Related]
36. A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial. García IG; Rodriguez-Rubio M; Mariblanca AR; de Soto LM; García LD; Villatoro JM; Parada JQ; Meseguer ES; Rosales MJ; González J; Arribas JR; Carcas AJ; de la Oliva P; Borobia AM Trials; 2020 Jun; 21(1):466. PubMed ID: 32493475 [TBL] [Abstract][Full Text] [Related]
37. Erythema multiforme in the context of SARS-Coronavirus-2 infection. Sánchez-Velázquez A; Falkenhain D; Rivera Díaz R Med Clin (Barc); 2020 Aug; 155(3):141. PubMed ID: 32475615 [No Abstract] [Full Text] [Related]
38. Systematic Review on Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: It Is Time to Take Stock. D'Amico F; Danese S; Peyrin-Biroulet L Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2689-2700. PubMed ID: 32777550 [TBL] [Abstract][Full Text] [Related]
39. Applying the Lessons of Influenza to COVID-19 During a Time of Uncertainty. Vardeny O; Madjid M; Solomon SD Circulation; 2020 May; 141(21):1667-1669. PubMed ID: 32208975 [No Abstract] [Full Text] [Related]
40. Best Practice Guidance for Adult Infusion Centres during the COVID-19 Pandemic: Report from the COVID-19 International Organization for the Study of IBD [IOIBD] Task Force. Dotan I; Panaccione R; Kaplan GG; O'Morain C; Lindsay JO; Abreu MT J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S785-S790. PubMed ID: 32959882 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]